Thoracic paravertebral block for breast cancer surgery: a randomized double-blind study

Anesth Analg. 2007 Dec;105(6):1848-51, table of contents. doi: 10.1213/01.ane.0000286135.21333.fd.

Abstract

Background: We examined in this randomized, double-blind study whether a multilevel paravertebral block performed before general anesthesia with propofol and a laryngeal mask enhances postoperative analgesia after breast cancer surgery.

Methods: Eighty-eight patients were randomized to receive paravertebral injections with either ropivacaine 0.5% (30 mL) or an equivalent amount of isotonic saline. Nine patients were excluded after randomization, thus 79 patients remained for evaluation (ropivacaine, n = 38; placebo, n = 41). Variables of efficacy were the amount of fentanyl delivered by the patient-controlled analgesia device in the postanesthesia care unit (PACU), postoperative pain measured on a numeric rating scale at regular intervals from the day of surgery and until the second postoperative day.

Results: The median consumption of fentanyl in the PACU was less in the ropivacaine group compared with the placebo group (0 microg [range: 0-250 microg] versus 100 microg [range: 0-800 microg], P = 0.001). Also, fewer patients in the ropivacaine group reported pain > or =3 on the numbers rating scale in the PACU (13 vs 31, P < 0.0001). No statistical difference in pain scores or consumption of analgesics could be demonstrated after discharge from the PACU.

Conclusions: A multilevel paravertebral block provides good analgesia for breast surgery, but the duration of analgesia is briefer than described in previous studies.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / surgery*
  • Double-Blind Method
  • Female
  • Humans
  • Middle Aged
  • Nerve Block / methods*
  • Pain Measurement / methods
  • Thoracic Surgical Procedures / methods*